Seed VC · USA

Orbimed

Active

What they invest in

OrbiMed seeks to invest globally in world-class healthcare companies to help drive innovation, address unmet medical needs, and improve patient outcomes. The firm invests across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.

Who they back

DeepTechHealthtechBiotechSeedSeries ASeries B+

Business models

deeptech_ip, biotech_therapeutics, platform

Customer segments

Enterprise, Researchers

Geography

US, Europe, APAC, MENA

Recent investments

  • ADARx
  • Treeline Biosciences
  • Mirador Therapeutics

+ 3 more deals. Score your deck to see the full investment history.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Orbimed writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Orbimed alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
United States
Last known deal
Dec 2015
Portfolio last checked
Oct 6, 2026
Website
www.orbimed.com ↗

Other firms investing in DeepTech

See all investors

Is Orbimed the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Orbimed is one of them, and we'll tell you exactly where they sit in your top 100.